RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Farin Kamangar to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Back to Details
This is a "connection" page, showing publications Farin Kamangar has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Farin Kamangar
Connection Strength
0.147
Hydroxymethylglutaryl-CoA Reductase Inhibitors
  1. Nalini M, Sepanlou SG, Pourshams A, Poustchi H, Sharafkhah M, Bahrami H, Kamangar F, Malekzadeh R. Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study. Arch Iran Med. 2018 03 01; 21(3):86-94.
    View in: PubMed
    Score: 0.147
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support